1. Investigating the in vitro antibacterial, antibiofilm, antioxidant, anticancer and antiviral activities of zinc oxide nanoparticles biofabricated from Cassia javanica.
- Author
-
Almuhayawi MS, Alruhaili MH, Soliman MKY, Tarabulsi MK, Ashy RA, Saddiq AA, Selim S, Alruwaili Y, and Salem SS
- Subjects
- Humans, Animals, Chlorocebus aethiops, Vero Cells, Metal Nanoparticles chemistry, Methicillin-Resistant Staphylococcus aureus drug effects, Plant Extracts pharmacology, Plant Extracts chemistry, Nanoparticles chemistry, Zinc Oxide pharmacology, Zinc Oxide chemistry, Anti-Bacterial Agents pharmacology, Anti-Bacterial Agents chemistry, Biofilms drug effects, Antioxidants pharmacology, Antioxidants chemistry, Antiviral Agents pharmacology, Antiviral Agents chemistry, Microbial Sensitivity Tests, Cassia chemistry, Antineoplastic Agents pharmacology, Antineoplastic Agents chemistry
- Abstract
It is thought to be risk-free, environmentally benign, and safe for biological processes to produce zinc oxide nanoparticles from renewable resources. This study examined Cassia javanica's ability to create ZnONPs. The generated ZnONPs were analyzed using a variety of techniques, such as TEM, FTIR spectroscopy, UV-Vis spectroscopy, and XRD analysis. The antibacterial potential of ZnONPs has been investigated using both Agar well diffusion and microtitreplate (MTP) methods. One method used to evaluate ZnONPs' capacity to scavenge free radicals at different concentrations was the DPPH method. The permanent zinc oxide (ZnO) shape and the naturally occurring crystal structure of ZnONPs were validated by the XRD data. ZnONPs showed antibacterial activity with MICs of 31.7 μg/mL toward Bacillus subtilis, 62.5 μg/mL for Salmonella typhimurium, Escherichia coli while Clostridium sporogenes and Bacillus pumilus was 125μg/mL. Furthermore, ZnONPs demonstrated a range of antibiofilm activities toward Staphylococcus aureus (MRSA). ZnONPs showed an intriguing antioxidant capacity, achieving IC50 of 109.3 μg/ml μg/mL. Additionally, ZnONPs demonstrated low toxic effect on Vero cell with IC50 154.01 μg/mL as well as possible anticancer action when applied to the carcinoma cell lines HepG2 with IC50 of 47.48 μg/mL. Furthermore, ZnONPs at 62.5 μg/mL had a promising antiviral impact against HSV1 and COX B4, with antiviral activities of 75.4% and 65.8%, respectively., Competing Interests: The authors have declared that no competing interests exist., (Copyright: © 2024 Almuhayawi et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.)
- Published
- 2024
- Full Text
- View/download PDF